Using a coloring agent in the mist, they could track the drug to certain areas of the lungs. Researchers also found that breathing in slowly and deeply dispersed medication further into the lungs. Inhaling quickly sent the mist to different areas. Using this information, doctors can target the medication to areas of the lungs that need it. Gene therapy is offering the newest hope for CF patients.
Several studies are underway to come up with gene-carrying treatments.
The John Hopkins researchers hope this study will also provide offer a more efficient delivery system for those medications once they become available.